Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNMT | P11086 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | RPS6KA1 | Q15418 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 4/20 | 0.33 |
| ▸ | HTR1B | P28222 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3764508 | 0.92 | HTR1B (0.35) | PNMTKDM4EHPGDSMN1; SMN2RPS6KA1 | |
| SCHEMBL3770772 | 0.91 | ADRB2 (0.34) | PNMTKDM4EHPGDSMN1; SMN2RPS6KA1 | |
| Hydrochloric Acid SCHEMBL921369 | 0.91 | KDM4E (0.37) | PNMTKDM4EHPGDSMN1; SMN2RPS6KA1 | |
| SCHEMBL3776746 | 0.89 | ALDH1A1 (0.36) | PNMTKDM4EHPGDSMN1; SMN2RPS6KA1 | |
| SCHEMBL3764905 | 0.89 | ALDH1A1 (0.36) | PNMTKDM4EHPGDSMN1; SMN2RPS6KA1 | |
| Hydrochloric Acid SCHEMBL920158 | 0.89 | KDM4E (0.36) | PNMTKDM4EHPGDSMN1; SMN2RPS6KA1 | |
| SCHEMBL3766553 | 0.83 | MAPT (0.46) | PNMTRPS6KA1MAOBMAPTLOXL2 | |
| SCHEMBL3771148 | 0.81 | RPS6KA1 (0.35) | PNMTKDM4EHPGDSMN1; SMN2RPS6KA1 | |
| SCHEMBL3764651 | 0.80 | CYP1A2 (0.35) | KDM4EHPGDSMN1; SMN2RPS6KA1MAOB | |
| SCHEMBL3764404 | 0.80 | RPS6KA1 (0.34) | KDM4EHPGDSMN1; SMN2RPS6KA1MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100311790-A1 | AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME | SUMITOMO CHIEMCAL COMPANY LIMITED (JP) | 2010-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100311790-A1 | AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME | ATL3, NAT1, C5 | PNMT 695/4885KDM4E 2021/4885HPGD 4316/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.